Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Medical Device Contract Manufacturing Market 2026, Impact Of Industry 4.0 On The Medical Device Industry to Boost Growth - Technavio

NEW YORK, Oct. 3, 2022 /PRNewswire/ -- The Medical Device Contract Manufacturing Market size is expected to grow by USD 46.18 bn during 2021-2026, at a CAGR of 11.19% during the forecast period, according to Technavio. The Impact of Industry 4.0 on the medical device industry, strategic M&A, and high investments in R&D will offer immense growth opportunities.

However, consolidation in the medical device industry, stringent regulations associated with medical device manufacturing, and unfavorable reimbursement scenarios will challenge the growth of the market participants.

To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments. Buy Sample Report.

Medical Device Contract Manufacturing Market Vendors Analysis

We provide a detailed analysis of around 25 vendors operating in the Medical Device Contract Manufacturing Market, including some of the vendors such as vendors Backed with competitive intelligence and benchmarking, our research reports on the Medical Device Contract Manufacturing Market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.

Find additional highlights on the growth strategies adopted by vendors and their product offerings, Download Free Sample Report.

Medical Device Contract Manufacturing Market Segmentation

Medical Device Contract Manufacturing Market Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our medical device contract manufacturing market report covers the following areas:

This study identifies the shift from centralized to point-of-care testing as one of the prime reasons driving the medical device contract manufacturing market growth during the next few years. Request Free Sample Report.

Related Reports:
Hysterometers Market by End-user, Type, and Geography - Forecast and Analysis 2022-2026

Dermatology Endoscopy Devices Market by Product and Geography - Forecast and Analysis 2022-2026

Medical Device Contract Manufacturing Market Scope

Report Coverage


Page number


Base year


Forecast period


Growth momentum & CAGR

Accelerate at a CAGR of 11.19%

Market growth 2022-2026

$46.18 billion

Market structure


YoY growth (%)


Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 38%

Key consumer countries

US, Canada, Germany, China, Japan, and Republic of Korea

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Benchmark Electronics Inc., Celestica Inc., Flex Ltd., Gerresheimer AG, Integer Holdings Corp., Jabil Inc., Kimball Electronics Inc., Nemera, Nipro Corp., Nordson Corp., Nortech Systems Inc., Plexus Corp., Recipharm AB, Sanmina Corp., Scientific Molding Corp. Ltd., TE Connectivity Ltd., Tecomet Inc., Teleflex Inc., Tessy Plastics Corp., and West Pharmaceutical Services Inc.

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table Of Contents :

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Five Forces Analysis

5 Market Segmentation by Device

6 Customer Landscape

7 Geographic Landscape

8 Drivers, Challenges, and Trends

9 Vendor Landscape

10 Vendor Analysis

11 Appendix

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio

These press releases may also interest you

at 16:15
Hapbee Technologies, Inc.    ("Hapbee" or the "Company"), the digital wellness technology company, announced today that all six director nominees proposed in the Company's management information circular dated October 28, 2022 (the "Information...

at 16:15
Fusion Pharmaceuticals Inc. , a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that the compensation committee of the Company's Board of Directors granted stock...

at 16:15
CPC (Colder Products Company), part of Dover  and a leading manufacturer of connection technologies used in biopharmaceutical processing, today announced that its MicroCNX® Series Connectors were named a 2022 Pharma Innovation Award winner. The award...

at 16:11
Virginia Mason Medical Center in Seattle was named a Top Teaching Hospital nationally by The Leapfrog Group in recognition of their achievements in patient safety and quality. Top Hospitals were honored at the 2022 Leapfrog Annual Meeting and Awards...

at 16:10
IMV Inc. (the "Corporation") , a clinical-stage biopharmaceutical company developing a portfolio of immune-educating therapies based on its novel DPX® platform to treat solid and hematologic cancers, announced today that at the special meeting of...

at 16:05
Kezar Life Sciences, Inc. , a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that the Compensation Committee of the company's Board of Directors...

News published on 3 october 2022 at 18:45 and distributed by: